Chang-Kang-Fang Ameliorates Experimental Diarrhea Predominant Irritable Bowel Syndrome by Regulating Gut Microbiota and Gut -Brain Axis
暂无分享,去创建一个
Jingyi Hu | Kong Weiqian | Y. Zheng | Hui Xie | Xin-Rong Fan | Min Lu | Ruyi Ji
[1] S. Sacco,et al. Gut-brain Axis and migraine headache: a comprehensive review , 2020, The Journal of Headache and Pain.
[2] Fei Li,et al. Effect of water extract from Berberis heteropoda Schrenk roots on diarrhea-predominant irritable bowel syndrome by adjusting intestinal flora. , 2019, Journal of ethnopharmacology.
[3] Ying Xu,et al. Resveratrol Improves Brain-Gut Axis by Regulation of 5-HT-Dependent Signaling in the Rat Model of Irritable Bowel Syndrome , 2019, Front. Cell. Neurosci..
[4] B. Lacy,et al. Management of irritable bowel syndrome with diarrhea: a review of nonpharmacological and pharmacological interventions , 2019, Therapeutic advances in gastroenterology.
[5] Morris A. Swertz,et al. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome , 2018, Science Translational Medicine.
[6] Harry Sokol,et al. Gut Microbiota Regulation of Tryptophan Metabolism in Health and Disease. , 2018, Cell host & microbe.
[7] Xia Li,et al. Chemical profiles and pharmacological activities of Chang-Kang-Fang, a multi-herb Chinese medicinal formula, for treating irritable bowel syndrome. , 2017, Journal of ethnopharmacology.
[8] Tao-Tao Liu,et al. Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis. , 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[9] J. Sonnenburg,et al. Gut microbes promote colonic serotonin production through an effect of short‐chain fatty acids on enterochromaffin cells , 2015, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[10] Paul J Kennedy,et al. Irritable bowel syndrome: a microbiome-gut-brain axis disorder? , 2014, World journal of gastroenterology.
[11] W. Chung,et al. Effect of multispecies probiotics on irritable bowel syndrome: A randomized, double‐blind, placebo‐controlled trial , 2014, Journal of gastroenterology and hepatology.
[12] M. Bellini,et al. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome , 2014, Techniques in Coloproctology.
[13] Jerrold R. Turner,et al. Intestinal mucosal barrier function in health and disease , 2009, Nature Reviews Immunology.
[14] S. Ahrné,et al. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome , 2000, American Journal of Gastroenterology.
[15] G. Sturniolo,et al. [Irritable bowel syndrome]. , 1988, Giornale di clinica medica.